InvestorsObserver
×
News Home

Should You Accumulate Taysha Gene Therapies Inc (TSHA) Stock Tuesday Morning?

Tuesday, March 26, 2024 06:42 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Taysha Gene Therapies Inc (TSHA) Stock Tuesday Morning?

Taysha Gene Therapies Inc (TSHA) is down -4.90%% today.

Overall Score - 89
TSHA has an Overall Score of 89. Find out what this means to you and get the rest of the rankings on TSHA!
TSHA stock closed at $3.06 and is down -$0.15 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. TSHA has a strong overall score of 89 meaning the stock holds a better value than 89% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. TSHA gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Taysha Gene Therapies Inc currently has the 101th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders.
Taysha Gene Therapies Inc's Overall and Short-Term Technical score paint a strong picture for TSHA's recent trading patterns and forecasted price. Click Here To Get The Full Report on Taysha Gene Therapies Inc (TSHA)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App